Skip to Main content Skip to Navigation
Poster communications

Cell therapy with engineered HLA-A2 specific CAR-CD8+Tregs to avoid transplant rejection

Document type :
Poster communications
Complete list of metadatas

https://www.hal.inserm.fr/inserm-02161857
Contributor : Sylvie Le Bihan <>
Submitted on : Friday, June 21, 2019 - 10:50:40 AM
Last modification on : Friday, August 2, 2019 - 11:26:16 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

  • HAL Id : inserm-02161857, version 1

Collections

Citation

Séverine Bézie, Béatrice Charreau, Nadège Vimond, Juliette Lasselin, Véronique Daguin, et al.. Cell therapy with engineered HLA-A2 specific CAR-CD8+Tregs to avoid transplant rejection. Bioregate 2018, Dec 2018, Nantes, France. ⟨inserm-02161857⟩

Share

Metrics

Record views

42